Obesity, Obesity-related Metabolic Conditions, and Risk of Thyroid Cancer in Women: Results from a Prospective Cohort Study (Sister Study)
Overview
Affiliations
Background: Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesity-related metabolic conditions with thyroid cancer incidence.
Methods: From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits.
Findings: During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] = 1.25, 95% CI = 1.14-1.37), waist circumference (HR = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer.
Interpretation: In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesity-related metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.
Funding: This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Institute of Environmental Health Sciences (Z01-ES044005).
Croce L, Ruggeri R, Virili C, Cappelli C, Teliti M, Costa P Eur Thyroid J. 2025; .
PMID: 39841635 PMC: 11825167. DOI: 10.1530/ETJ-24-0190.
Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S Br J Cancer. 2024; 131(9):1480-1495.
PMID: 39317703 PMC: 11519895. DOI: 10.1038/s41416-024-02857-7.
Zhang X, Zhu L, Ma C, Zhao S, Zhao C, Sun H Reprod Sci. 2024; 31(11):3569-3582.
PMID: 39060752 PMC: 11527956. DOI: 10.1007/s43032-024-01652-2.
Shi X, Deng G, Wen H, Lin A, Wang H, Zhu L J Glob Health. 2024; 14:04067.
PMID: 38547495 PMC: 10978059. DOI: 10.7189/jogh.14.04067.
Rusiecki J, McAdam J, Denic-Roberts H, Sjodin A, Davis M, Jones R Environ Health. 2024; 23(1):28.
PMID: 38504322 PMC: 10949709. DOI: 10.1186/s12940-024-01068-0.